Deucravacitinib for Plaque Psoriasis Shows Improved Patient ...

Dermatology Advisor - 16 Sep 2024
Improvements in 2 patient-reported outcome measures were observed among patients with psoriasis treated with deucravacitinib vs placebo or apremilast.

Psoriasis Severity, Systemic Inflammation Associated with Cardiovascular Disease

MD Magazine - 23 Nov 2024
Psoriasis Severity, Systemic Inflammation Associated with Cardiovascular Disease ...

J&J pill clears skin in two late-stage psoriasis studies

BioPharma Dive - 19 Nov 2024
J&J pill clears skin in two late-stage psoriasis studies ...

Profiling CARD14 gene expression in Indian Psoriasis patients

Nature.com - 20 Nov 2024
Profiling CARD14 gene expression in Indian Psoriasis patients ...

JNJ-2113 Shows Promising Phase 3 Results for Plaque Psoriasis

Dermatology Times - 19 Nov 2024
JNJ-2113 Shows Promising Phase 3 Results for Plaque Psoriasis ...

J&J, Protagonist's oral psoriasis prospect scores in phase 3 pair, readying case against BMS' Sotyktu

Fierce Biotech - 19 Nov 2024
J&J, Protagonist's oral psoriasis prospect scores in phase 3 pair, readying case against BMS' Sotyktu ...

Oral IL-23 inhibitor icotrokinra shows efficacy for plaque psoriasis

Healio - 21 Nov 2024
Oral IL-23 inhibitor icotrokinra shows efficacy for plaque psoriasis ...

The Role of Ultrasound in Psoriatic Arthritis Diagnosis

Medscape - 22 Nov 2024
The Role of Ultrasound in Psoriatic Arthritis Diagnosis ...

Psoriasis around the world

Bristol Myers Squibb - 28 Oct 2024
Psoriasis around the world ...

New phase 3 data of JNJ-2113 for plaque psoriasis in patients aged 12 years, older

Contemporary Pediatrics - 20 Nov 2024
New phase 3 data of JNJ-2113 for plaque psoriasis in patients aged 12 years, older ...

New Pricing Solution in Obesity and Psoriatic Disease

Eli Lilly - 18 Nov 2024
New Pricing Solution in Obesity and Psoriatic Disease ...

Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis

Clinical Trials Arena - 19 Nov 2024
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis ...

Psoriasis Relief Starts Here: These 8 Shampoos Are Dermatologist-Approved to Soothe Your Scalp

Verywell Health - 19 Nov 2024
Psoriasis Relief Starts Here: These 8 Shampoos Are Dermatologist-Approved to Soothe Your Scalp ...

Psoriasis Patients Likely to Use Light Therapy Treatment at Home

Penn Medicine - 24 Oct 2024
Psoriasis Patients Likely to Use Light Therapy Treatment at Home ...

Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug

OutSourcing-Pharma.com - 21 Nov 2024
Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug ...

Psoriasis

UF Health - 03 Oct 2024
Psoriasis ...

World Psoriasis Day 2024: Celebrating the invaluable role of family

UCB - 29 Oct 2024
World Psoriasis Day 2024: Celebrating the invaluable role of family ...

Phototherapy for Psoriasis: Benefits, Risks, and Treatment Options

Everyday Health - 13 Nov 2024
Phototherapy for Psoriasis: Benefits, Risks, and Treatment Options ...

Bilayered skin equivalent mimicking psoriasis as predictive tool for preclinical treatment studies

Nature.com - 18 Nov 2024
Bilayered skin equivalent mimicking psoriasis as predictive tool for preclinical treatment studies ...

Subgroup Analysis Reveals Equal Benefit of Brodalumab in Obese vs Non-Obese Patients With Psoriasis

Dermatology Times - 22 Nov 2024
Subgroup Analysis Reveals Equal Benefit of Brodalumab in Obese vs Non-Obese Patients With Psoriasis ...

Psoriasis